A new medication called JZP-258 shows promise in the treatment of sleep apnea. In a study published in the Journal of Clinical Sleep Medicine, researchers found that the drug helped reduce the number of apneic events (when breathing stops) by up to 70%.
Sleep apnea is a serious condition that can lead to other health problems, including high blood pressure and heart disease. The new drug, which is taken once a day, could provide a much needed treatment option for the estimated 18 million Americans who suffer from sleep apnea.
While more research is needed, the findings are encouraging and provide hope for those who suffer from this potentially dangerous condition.
Sleep apnea is a condition in which a person repeatedly stops breathing during the night. It can cause serious health problems, including high blood pressure, heart disease, and stroke.
There is no cure for sleep apnea, but there are treatments that can help. One promising treatment is a medication called suvorexant.
Suvorexant is a new type of medication that works by blocking the chemical receptors in the brain that keep us awake. It is similar to other medications used to treat insomnia, but it is more effective and has fewer side effects.
A recent study found that suvorexant was effective in treating sleep apnea. The study participants who took suvorexant had significantly less sleep apnea than those who took a placebo. They also had less daytime sleepiness and improved quality of life.
Suvorexant is not yet approved by the FDA for the treatment of sleep apnea, but it is expected to be approved in the near future. If you are interested in trying this medication, talk to your doctor.
